DSP Healthcare Fund - Direct Plan - Growth
DSP Investment Managers Private Limited · Direct Plan · Growth
Fund overview
0.50% on or before 1M, Nil after 1M
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹1,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹1,000 | ₹1,221 | +221 |
| 3 Years | ₹1,000 | ₹1,820 | +820 |
| 5 Years | ₹1,000 | ₹2,713 | +1,713 |
Calculated using the fund's annualised return since inception (22.1% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
32 securitiesTop 10 holdings make up 58.2% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| Ipca Laboratories Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 8.13% |
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals & Biotechnology | Large Cap | 7.44% |
| Cipla Ltd | Pharmaceuticals & Biotechnology | Large Cap | 7.18% |
| TREPS / Reverse Repo Investments | Cash/Deposits/Margins/Treps/Repo/Swaps | — | 6.81% |
| SAI Life Sciences Ltd | Pharmaceuticals & Biotechnology | Small Cap | 6.52% |
| Gland Pharma Ltd | Pharmaceuticals & Biotechnology | Small Cap | 6.15% |
| Apollo Hospitals Enterprises Ltd | Healthcare Services | Large Cap | 6.07% |
| Globus Medical Inc | Healthcare Services | Overseas Equity | 5.15% |
| Alkem Laboratories Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 4.75% |
| Divi'S Laboratories Ltd | Pharmaceuticals & Biotechnology | Large Cap | 4.17% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹3,750 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹3,498 Cr
Exit load, stamp duty & tax
30-Nov-18
0.50% on or before 1M, Nil after 1M
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | 13.88% |
| Beta | 0.84 |
| Sharpe Ratio | 2.86 |
| Sortino Ratio | -0.19 |
| Treynor Ratio | 0.47 |
| Jensen's Alpha | 2.92 |
| Information Ratio | -0.19 |
| R-Squared | 94.45% |
| Max Drawdown | -3.00% |
| Upside Capture | 85.55% |
| Downside Capture | 61.06% |
Fund management
Scheme Details
Investment objective
The Primary Investment Objective Of The Scheme Is To Seek To Generate Consistent Returns Bypredominantly Investing In Equity And Equity Related Securities Of Pharmaceutical And Healthcarecompanies.
Fund house
DSP Investment Managers Private Limited
Frequently asked questions
What is the NAV of DSP Healthcare Fund - Direct Plan - Growth?
The NAV of DSP Healthcare Fund - Direct Plan - Growth is ₹48.35 as of 19 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by DSP Healthcare Fund - Direct Plan - Growth?
The expense ratio charged by DSP Healthcare Fund - Direct Plan - Growth is 0.75%.
What is the Min. SIP of DSP Healthcare Fund - Direct Plan - Growth?
The minimum SIP investment in DSP Healthcare Fund - Direct Plan - Growth is ₹100 per month.
What is the Min. Lumpsum of DSP Healthcare Fund - Direct Plan - Growth?
The minimum lumpsum investment in DSP Healthcare Fund - Direct Plan - Growth is ₹100.
What is the Exit Load of DSP Healthcare Fund - Direct Plan - Growth?
The exit load for DSP Healthcare Fund - Direct Plan - Growth is: 0.50% on or before 1M, Nil after 1M
.svg){kind=small}